Where can researchers source third-party tested Selank?

Midwest Peptide supplies research-grade Selank with a Certificate of Analysis included for every batch, validated by HPLC purity and mass spectrometry identity testing.

Age Verification

You must be 21 years or older to access this website. All products are for research use only.

Are you 21 years of age or older?

By entering, you confirm that you are at least 21 years old and agree to our terms of service.

Memorial Day: 15% off code MEMDAY15Memorial Day Sale — 15% off site-wide with code MEMDAY15

Free shipping on every orderFree shipping on every order

5% off with Zelle or Apple CashSave an extra 5% when you pay with Zelle or Apple Cash

Bulk pricing discounts up to 18%Bulk pricing discounts up to 18% off

Selank Tuftsin Research: Russian History | Midwest Peptide

Selank GABA Research: Anxiolytic Studies in Animal ModelsPrev|Selank in Research: A Review of the Synthetic Heptapeptide LiteratureNext

Selank Tuftsin Research: Russian Peptide Research History

Q: Is Selank approved for human use?

No. Selank is not approved by the FDA for any human therapeutic use. It is supplied strictly for in-vitro and preclinical research purposes by qualified investigators.

Selank · Published April 9, 2026 · Updated May 18, 2026 · 8 min read

Quick Answer

Selank tuftsin research covers the natural tuftsin tetrapeptide, the Russian peptide research program, and the structural design that produced Selank. This article examines the historical development, structure-activity relationships, and tuftsin-inherited immune and behavioral activity underlying Selank research. For research use only, not for human consumption.

Selank Tuftsin Research: Russian Peptide Research History

Research Use Only. All products are strictly for research use only (RUO). Not for human consumption. Products on this site are not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. By purchasing, you agree that you are a qualified researcher and that products will be used solely for in-vitro research purposes.

What Is Tuftsin?
Tuftsin Limitations as a Research Tool
The Russian Peptide Research Program
Selank's Structural Design
Tuftsin Biology in the Selank Context
Selank Within the Broader Synthetic Peptide Landscape
Open Research Questions
Conclusion
Related Research Articles
Explore Related Products
Frequently Asked Questions
Glossary

Selank tuftsin research provides the historical and biochemical foundation for understanding Selank as a research tool. Selank is structurally derived from tuftsin, a small natural peptide originally isolated from immunoglobulin G in the 1970s. The Selank molecule extends the tuftsin sequence with a stabilizing tripeptide tail to create a synthetic research peptide with improved stability for laboratory applications. As the historical and structural background component of the Selank research cluster, this article reviews the published literature on tuftsin biology, the Russian peptide research program that produced Selank, and the structural relationship between tuftsin and Selank.

Frequently Asked Questions

What is Selank in research contexts?

Selank is a synthetic heptapeptide derived from the natural immunomodulatory tetrapeptide tuftsin and developed in Russian neuropeptide research. It is studied in preclinical models for anxiolytic effects, GABAergic modulation, BDNF expression, and immunomodulatory activity.

How was Selank developed from tuftsin?

Selank was developed at the V.V. Zakusov Research Institute by extending tuftsin (Thr-Lys-Pro-Arg) with a Pro-Gly-Pro tail (Thr-Lys-Pro-Arg-Pro-Gly-Pro). The C-terminal extension enhanced metabolic stability while preserving the parent tuftsin's biological activities.

What was the Russian peptide research program?

The Russian Academy of Sciences pursued endogenous regulatory peptides as therapeutic templates, generating Selank, Semax, and other neuropeptide research tools. The program emphasized intranasal delivery, modified endogenous sequences, and integrated neuropsychiatric and immune effects.

Is Selank approved for human use?

Glossary

Key terms used in this article.

Tuftsin: An endogenous tetrapeptide (Thr-Lys-Pro-Arg) liberated from the Fc domain of immunoglobulin G, the structural basis for Selank.
GABAergic: Pertaining to neurons, synapses, or signaling pathways using gamma-aminobutyric acid (GABA), the primary inhibitory neurotransmitter.
Anxiolytic: Pertaining to compounds that reduce anxiety in behavioral or physiological studies.
BDNF: Brain-derived neurotrophic factor, a key neurotrophin supporting neuronal survival, synaptic plasticity, and learning.
Heptapeptide: A peptide consisting of seven amino acid residues; both Selank and Semax are heptapeptides.
Pro-Gly-Pro Tail: A three-amino-acid C-terminal extension on Selank and Semax that confers stability against carboxypeptidase degradation.
V.V. Zakusov Research Institute: The Russian research institute where Selank was developed under the broader Russian Academy of Sciences peptide research program.

More from the Blog

Continue exploring research insights and updates.

Subcutaneous vs Intranasal: Choosing an Administration Route for DSIP, Selank, and Kisspeptin in Research

Subcutaneous vs intranasal administration for CNS-targeted research peptides: how to choose between routes for DSIP, Selank, and Kisspeptin based on molecular size, brain access, pharmacokinetics, and the published literature.

May 5, 2026

Can I Still Buy Compounded Tirzepatide? (2026 Research Context)

FDA restricted compounded tirzepatide for human use when the shortage ended. The Research Use Only research peptide channel for tirzepatide (GLP-2 TZ) operates under entirely separate regulations.

May 5, 2026

For Research Use Only. Selank is intended exclusively for in vitro and preclinical research. It is not approved for human use, is not a drug, and should never be administered to humans or to animals outside of an authorized research protocol.

What Is Tuftsin?

Tuftsin is a small natural peptide consisting of four amino acids: threonine, lysine, proline, and arginine (Thr-Lys-Pro-Arg). It was first isolated and characterized in the 1970s from the heavy chain of immunoglobulin G, specifically from a region within the Fc portion of the antibody. The peptide is generated by enzymatic cleavage of immunoglobulin G in research conditions, releasing the free tetrapeptide that exhibits biological activity distinct from the parent immunoglobulin.

Tuftsin was named for Tufts University, where it was identified by researchers studying immunoregulatory factors derived from immunoglobulin G. The original research interest was in factors that could modulate phagocytic cell function, and tuftsin was characterized as a peptide with effects on macrophage and neutrophil activity in research models.

The biological activity of tuftsin extends beyond its initial characterization as an immunoregulatory peptide. Subsequent research has examined tuftsin effects on the central nervous system, on inflammatory responses, and on various other endpoints in research models. This broader research base provided the foundation for the development of synthetic tuftsin analogs like Selank that could be used as more stable research tools.

Tuftsin Limitations as a Research Tool

Despite its biological activity, natural tuftsin has significant limitations as a research tool. The most important limitation is its short half life in research models, due to rapid enzymatic cleavage by aminopeptidases and other proteases that degrade small peptides in plasma and tissue fluids. The N-terminal threonine residue makes tuftsin particularly vulnerable to aminopeptidase activity, which removes amino acids from the N-terminal end of peptides.

The rapid clearance of natural tuftsin limits its utility for research applications that require sustained effects or precise control over the timing of peptide exposure. Studies of tuftsin in research models typically require either continuous infusion or very frequent administration, both of which add operational complexity and may produce variability in receptor activation across the experiment.

These limitations motivated the development of more stable tuftsin analogs that could be used as research tools without the rapid degradation. Several approaches were used to address the stability problem, including N-terminal modifications, amino acid substitutions, and the addition of stabilizing tail sequences. Selank emerged from this work as one of the more successful approaches, using a Pro-Gly-Pro tripeptide tail to extend the stability of the molecule while preserving the active tuftsin sequence.

The Russian Peptide Research Program

Selank was developed at the V.V. Zakusov Institute of Pharmacology in Moscow, Russia, as part of a broader Russian peptide research program that has produced multiple synthetic neuropeptide research tools over several decades. The institute has a long tradition of peptide research, including foundational work on neuropeptide structure and function and applied research on synthetic analogs designed for specific research applications.

The Russian peptide research program developed somewhat in parallel with Western peptide research but with different research priorities and different specific compounds. Several synthetic peptides developed in this program have become reference compounds in international research literature, including Selank and Semax (an ACTH(4-10) derived heptapeptide studied in research). These peptides are sometimes grouped together as "Russian nootropic peptides" in the broader research literature.

The research program has produced peptides for studies on anxiety, cognition, immune function, and various other endpoints in research models. The synthetic peptides developed in this program were designed with stability considerations from the beginning, addressing the rapid clearance issues that limit natural peptide research tools.

For more on Semax, the other major Russian neuropeptide developed at the same institute, see our Semax Neuroinflammation Research: Microglial Modulation.

Selank's Structural Design

Selank's structural design addresses the stability limitations of natural tuftsin while preserving its active sequence. The molecule consists of seven amino acids: the four amino acids of tuftsin (Thr-Lys-Pro-Arg) followed by a Pro-Gly-Pro tripeptide tail. The added tripeptide tail provides protection against aminopeptidase cleavage and other enzymatic degradation pathways that affect natural tuftsin.

The Pro-Gly-Pro stabilizing tail is one of the more interesting design features of Selank. Proline residues are known to confer resistance to many proteolytic enzymes, since most proteases have difficulty cleaving peptide bonds adjacent to proline. The arrangement of two proline residues with a glycine in between creates a stable structural unit that protects the C-terminal portion of the molecule. The result is a peptide with significantly extended half life relative to natural tuftsin while retaining the biological activity associated with the tuftsin sequence.

The seven amino acid length of Selank places it in the heptapeptide category, which is a common length for synthetic neuropeptide research tools. Other research peptides in this length category include Semax (also a heptapeptide, but with different sequence and origin) and various other synthetic neuropeptides studied in research literature.

Tuftsin Biology in the Selank Context

Understanding tuftsin biology helps contextualize Selank as a research tool. Tuftsin acts on receptors expressed on phagocytic cells (macrophages, neutrophils) and on other immune cell types in research models, with effects on cellular activation, phagocytosis, and inflammatory responses. The tuftsin receptor system has been characterized in research, although the specific molecular identity of the receptor has been less clearly established than for many other peptide receptors.

Beyond its immunoregulatory effects, tuftsin has been studied for effects on the central nervous system, including modulation of neuronal function and behavioral endpoints in research animal models. These central effects provide one of the bases for the research interest in Selank as a tool for neuropeptide studies, since the tuftsin core sequence carries the active region that produces these effects.

Selank inherits the receptor binding properties of natural tuftsin while having improved stability for research applications. This makes Selank a useful tool for studying tuftsin biology in contexts where natural tuftsin would be impractical due to its rapid clearance.

Selank Within the Broader Synthetic Peptide Landscape

Selank is part of a broader category of synthetic research peptides developed to overcome the stability limitations of natural peptide ligands. Other examples in this category include stabilized GHRH analogs (such as tesamorelin and CJC-1295), stabilized GLP-1 receptor agonists (such as long-acting GLP-1 SM), and various other synthetic peptides designed with specific stability modifications for research use.

The general approach of stabilizing natural peptide sequences through amino acid substitutions, N-terminal modifications, or stabilizing tail sequences has produced many useful research tools. Selank represents a successful example of this approach applied to a small immunoregulatory peptide, providing a stable analog that retains the biological activity of natural tuftsin while being more practical for research applications.

For more on the broader pharmacological profile of Selank, see our companion articles on Selank GABA research and Selank BDNF research.

Open Research Questions

Several open research questions remain in the tuftsin and Selank historical literature. These include how the specific molecular receptor for tuftsin and its derivatives is identified and characterized in modern research, how the stability advantages of Selank translate quantitatively to functional improvements over natural tuftsin in research models, and how the tuftsin sequence in Selank interacts with downstream signaling pathways in different cell types. Each of these is a legitimate research opportunity for investigators studying tuftsin-derived peptides.

Conclusion

Selank tuftsin research provides the historical and biochemical foundation for understanding Selank as a research tool. The relationship between Selank and natural tuftsin, the development of Selank in the Russian peptide research program, and the structural design that confers improved stability all combine to position Selank as a useful research tool for studies of tuftsin-related biology. For investigators using Selank 10mg as a research tool, the historical and structural literature provides essential context for understanding the molecule.

For more on the full Selank research cluster, see the pillar overview article and the supporting articles on each major topic.

Selank is supplied by Midwest Peptide for research use only and is not intended for human administration.

Explore more peer-reviewed research and laboratory guides from our science team:

All products are third-party tested with a Certificate of Analysis (COA) included. For research use only.

Tesamorelin 10mg, 99%+ purity, COA included
VIP 10mg, 99%+ purity, COA included
GLP-1 SM 20mg, 99%+ purity, COA included
Selank 10mg, 99%+ purity, COA included
Semax 10mg, 99%+ purity, COA included

Browse All Research Peptides →

Age Verification

Selank Tuftsin Research: Russian Peptide Research History